
HTG Molecular Diagnostics HTGM
Geschäftsbericht 2022
hinzugefügt 30.03.2023
HTG Molecular Diagnostics ROCE 2011-2026 | HTGM
ROCE Jährlich HTG Molecular Diagnostics
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -219.45 | -171.39 | -70.04 | -52.35 | -43.97 | -223.93 | -288.52 | -57.02 | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| -43.97 | -288.52 | -140.83 |
ROCE Vierteljährlich HTG Molecular Diagnostics
| 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -142.22 | -158.25 | -110.42 | -76.93 | -45.74 | -63.58 | -65.39 | -86.37 | -89.58 | -108.86 | -110.3 | -87.7 | -53.39 | -76.17 | -79.67 | -87.01 | -66.82 | 99.95 | 289.49 | 488.8 | 524.28 | 632.61 | 574.17 | 507.87 | 341.26 | 312.7 | 175.81 | 34.1 | -80.19 | -75.69 | -42.62 | -9.53 | 13.58 | 13.58 | 9.08 | 3.95 | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 632.61 | -158.25 | 64.02 |
ROCE anderer Aktien in der Diagnostik & Forschung
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Centogene N.V.
CNTG
|
-89.9 | - | -6.23 % | $ 30.6 M | ||
|
Burning Rock Biotech Limited
BNR
|
-41.81 | $ 15.85 | -2.49 % | $ 171 M | ||
|
Agilent Technologies
A
|
25.0 | $ 115.06 | -0.29 % | $ 35 B | ||
|
Aspira Women's Health
AWH
|
114.15 | - | -6.19 % | $ 10.5 M | ||
|
Biocept
BIOC
|
-360.98 | - | -13.05 % | $ 7.29 M | ||
|
BioNano Genomics
BNGO
|
-75.05 | $ 1.13 | -2.59 % | $ 6.15 M | ||
|
Chembio Diagnostics
CEMI
|
-132.81 | - | 0.22 % | $ 16.8 M | ||
|
Check-Cap Ltd.
CHEK
|
1809.55 | - | - | $ 9.42 M | ||
|
DermTech
DMTK
|
-181.44 | - | -11.32 % | $ 2.94 M | ||
|
CareDx, Inc
CDNA
|
-10.16 | $ 16.05 | -3.83 % | $ 855 M | ||
|
Oxford Immunotec Global PLC
OXFD
|
-2.26 | - | - | $ 562 M | ||
|
Akumin
AKU
|
58.25 | - | -17.87 % | $ 25.9 M | ||
|
Enzo Biochem
ENZ
|
-22.04 | - | -8.98 % | $ 14.8 K | ||
|
Co-Diagnostics
CODX
|
-236.6 | $ 4.4 | 101.83 % | $ 5.85 M | ||
|
Exact Sciences Corporation
EXAS
|
-8.59 | - | - | $ 19.8 B | ||
|
Accelerate Diagnostics
AXDX
|
62.7 | - | -61.36 % | $ 2.46 M | ||
|
Castle Biosciences
CSTL
|
1.9 | $ 23.13 | -1.28 % | $ 642 M | ||
|
Global Cord Blood Corporation
CO
|
12.48 | - | - | $ 399 M | ||
|
Fluidigm Corporation
FLDM
|
-18.87 | - | 1.08 % | $ 308 M | ||
|
Genetic Technologies Limited
GENE
|
-347.69 | - | - | $ 7.1 B | ||
|
Genetron Holdings Limited
GTH
|
-15.41 | - | 0.12 % | $ 80.1 M | ||
|
Interpace Biosciences
IDXG
|
18.26 | $ 2.3 | - | $ 10.2 M | ||
|
Charles River Laboratories International
CRL
|
0.8 | $ 175.65 | 0.06 % | $ 8.71 B | ||
|
PRA Health Sciences, Inc.
PRAH
|
9.75 | - | - | $ 10.7 B | ||
|
Danaher Corporation
DHR
|
8.93 | $ 189.61 | -1.7 % | $ 135 B | ||
|
Heska Corporation
HSKA
|
-4.81 | - | - | $ 1.31 B | ||
|
Medpace Holdings
MEDP
|
116.53 | $ 493.53 | -1.59 % | $ 14.2 B | ||
|
Illumina
ILMN
|
-35.1 | $ 120.93 | -2.22 % | $ 19.2 B | ||
|
Fulgent Genetics
FLGT
|
-6.52 | $ 14.43 | -3.93 % | $ 436 M | ||
|
Myriad Genetics
MYGN
|
-105.22 | $ 4.35 | -2.03 % | $ 403 M | ||
|
NeoGenomics
NEO
|
-9.11 | $ 7.69 | -3.17 % | $ 985 M | ||
|
Guardant Health
GH
|
440.3 | $ 78.6 | -9.83 % | $ 9.85 B | ||
|
QIAGEN N.V.
QGEN
|
8.07 | - | - | $ 10.6 B | ||
|
Anixa Biosciences
ANIX
|
-77.18 | $ 2.69 | -1.82 % | $ 87.3 K | ||
|
Biomerica
BMRA
|
-125.14 | $ 2.13 | -0.9 % | $ 4.89 M | ||
|
Invitae Corporation
NVTA
|
-93.18 | - | - | $ 21.2 M | ||
|
Koninklijke Philips N.V.
PHG
|
6.33 | $ 28.31 | 0.62 % | $ 20 B | ||
|
ICON Public Limited Company
ICLR
|
4.69 | $ 106.81 | 0.1 % | $ 8.81 B | ||
|
Laboratory Corporation of America Holdings
LH
|
16.06 | $ 260.93 | -4.51 % | $ 21.7 B | ||
|
Natera
NTRA
|
-76.66 | $ 193.03 | -4.91 % | $ 19 B | ||
|
Celcuity
CELC
|
-171.24 | $ 117.14 | -6.02 % | $ 5.48 B | ||
|
Lantheus Holdings
LNTH
|
28.52 | $ 80.59 | -1.03 % | $ 5.44 B | ||
|
Motus GI Holdings
MOTS
|
-443.13 | - | -34.28 % | $ 263 K | ||
|
Quest Diagnostics Incorporated
DGX
|
21.7 | $ 191.51 | -3.19 % | $ 21.3 B | ||
|
Neogen Corporation
NEOG
|
-51.22 | $ 9.42 | -6.13 % | $ 2.04 B | ||
|
ENDRA Life Sciences
NDRA
|
-185.74 | $ 4.94 | -6.97 % | $ 3.89 M | ||
|
Organovo Holdings
ONVO
|
-120.24 | - | -2.3 % | $ 19.4 M | ||
|
OpGen
OPGN
|
4.4 | - | -16.95 % | $ 1.54 M | ||
|
National Research Corporation
NRC
|
161.47 | $ 16.48 | -3.34 % | $ 369 M |